about
Structural insights into calcium-bound S100P and the V domain of the RAGE complexNBPF1, a tumor suppressor candidate in neuroblastoma, exerts growth inhibitory effects by inducing a G1 cell cycle arrest.S100P antibody-mediated therapy as a new promising strategy for the treatment of pancreatic cancer.Expression and Distribution of Calcium-Binding Protein S100P in Human Placenta during Pregnancy.Animal Models of Gastrointestinal and Liver Diseases. The difficulty of animal modeling of pancreatic cancer for preclinical evaluation of therapeutics.High expression of S100P is associated with unfavorable prognosis and tumor progression in patients with epithelial ovarian cancerReversal of aberrant cancer methylome and transcriptome upon direct reprogramming of lung cancer cellsChanges in Expression of Genes Regulating Airway Inflammation Following a High-Fat Mixed Meal in Asthmatics.S100P expression in response to sex steroids during the implantation window in human endometrium.Functions of S100 proteins.S100P-derived RAGE antagonistic peptide reduces tumor growth and metastasis.Novel quantitative analysis of the S100P protein combined with endoscopic ultrasound-guided fine needle aspiration cytology in the diagnosis of pancreatic adenocarcinoma.Protein and non-protein biomarkers in melanoma: a critical update.S100 proteins as diagnostic and prognostic markers in colorectal and hepatocellular carcinoma.Molecular Biologic Approach to the Diagnosis of Pancreatic Carcinoma Using Specimens Obtained by EUS-Guided Fine Needle Aspiration.Joining S100 proteins and migration: for better or for worse, in sickness and in health.S100 proteins and the skin: a review.Differences in gene expression profiles and carcinogenesis pathways between colon and rectal cancer.The role of S100 proteins and their receptor RAGE in pancreatic cancer.Advanced Glycation End-Products Enhance Lung Cancer Cell Invasion and Migration.Interleukin-11: A Multifunctional Cytokine with Intrinsically Disordered Regions.Overexpression of S100P promotes colorectal cancer metastasis and decreases chemosensitivity to 5-FU in vitro.Ca2+/S100 proteins act as upstream regulators of the chaperone-associated ubiquitin ligase CHIP (C terminus of Hsc70-interacting protein)Plasma S100P level as a novel prognostic marker of metastatic breast cancer.Significance of S100P as a biomarker in diagnosis, prognosis and therapy of opisthorchiasis-associated cholangiocarcinoma.Circulating soluble advanced glycation end product is inversely associated with the significant risk of developing cancer: evidence from a meta-analysis.Clinicopathological significance of S100 protein expression in cholangiocarcinoma.S100A11 promotes human pancreatic cancer PANC-1 cell proliferation and is involved in the PI3K/AKT signaling pathway.Pathological spectrum of bile duct lesions from chronic bile duct injury to invasive cholangiocarcinoma corresponding to bile duct imaging findings of occupational cholangiocarcinoma.Proteomic alterations in early stage cervical cancer.Discovery of Novel and Clinically Relevant Markers in Formalin-Fixed Paraffin-Embedded Esophageal Cancer Specimen.Fatty Acids and Calcium Regulation in Prostate Cancer.
P2860
Q21131976-6C435942-CF93-4B93-BBBC-A6C0D87089EBQ30651336-EF1F68E6-5BA8-4BD7-A493-C8C97F271C37Q33685170-03BC9FFB-2B99-4719-8BB0-2CEF0E44ADA9Q35166399-3B4D62EE-6D0D-497D-81CB-F42458C5EE66Q36017810-44EB2794-6E08-4CA2-8047-6EAB5BEC98D5Q36057106-F46828B2-A4A6-476D-B89D-2A62324CDD0BQ36177485-006A5B3A-CD27-435A-AC44-AECA981E469AQ36507477-7D676A7C-54EB-445D-9406-09D32981F12CQ36552663-84DFF445-7010-4510-9FE9-3C77CBBE168AQ37001259-E83D31C3-0BAC-4D8E-9C35-B7ABA40CEC29Q37354472-E7AA90D7-C285-4927-A7A4-9B2D26DF390EQ37722098-E2C531B8-97E1-4412-AB3B-691BBF2897D6Q38050990-1B0322F1-45FD-4F6E-AB10-64F73D1A0877Q38061123-143748F8-C179-45C3-A4F0-F69CB06A0698Q38063856-170582C2-B9E1-4651-97A3-1005C7D7A88DQ38118075-96FE67C3-6881-42EA-937C-82F1842AEA41Q38127260-831EDEAA-1147-4919-A126-FE8D8B2A2ACBQ38329296-4CD01062-9A24-4A30-8CBC-51C820C33665Q38598852-3D9275EE-B45D-4503-B44C-8106F13AD099Q38752287-EFBEFA87-754D-4143-852B-F805730975C8Q38873802-D3F6543D-A81A-4CB6-8136-DBF955AA448CQ39038017-CB492941-E6D2-4260-85DB-665BEAB6FB36Q39205717-05DC9CB2-DCAC-425E-B661-F022478B516EQ40768670-D401EDAE-9D01-4A56-8A2D-544E21037FC4Q41030727-C0C9B066-69A5-44D9-BF4D-80D4EE727F64Q43742322-66E8C40D-1DFF-4BAF-A8D7-0BE5EC51FD57Q45222769-75B2882B-7AA6-4016-BD78-D624F640B041Q49467767-EF62B6B0-1008-48E7-AE8D-01FBA0E79ED2Q50277599-9038E241-066C-4B0F-AAD4-B60F1B9DB51CQ55040627-5D84B503-9F0F-446D-A09C-095EDD9BC8D4Q55286714-C6A20C94-1A17-4093-BDCE-9EF4DCB66092Q55468609-32D1B48F-6E6E-4600-A111-AD577BC21F6A
P2860
description
2010 nî lūn-bûn
@nan
2010 թուականի Մայիսին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի մայիսին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
S100P: a novel therapeutic target for cancer.
@ast
S100P: a novel therapeutic target for cancer.
@en
type
label
S100P: a novel therapeutic target for cancer.
@ast
S100P: a novel therapeutic target for cancer.
@en
prefLabel
S100P: a novel therapeutic target for cancer.
@ast
S100P: a novel therapeutic target for cancer.
@en
P2860
P1433
P1476
S100P: a novel therapeutic target for cancer.
@en
P2093
Craig D Logsdon
Thiruvengadam Arumugam
P2860
P2888
P304
P356
10.1007/S00726-010-0496-4
P577
2010-05-28T00:00:00Z